AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9014744
Drug: MivP chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MivP chemotherapy alone
Trial: 9014744
Drug: Lower doses
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower doses of intravenous clodronate combined with MivP
Trial: 3944815
Drug: Atropine 1.2
RxNorm normalized name: ATROPINE 1.2/NEOSTIGMINE 2.5MG/VIL INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine 1.2 mg
Trial: 6507825
Drug: Glycopyrronium 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycopyrronium 0.6 mg
Trial: 30342697
Drug: Once weekly
RxNorm normalized name: Actonel 35 4-Week Once Weekly Dosepack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once weekly dressing changes with negative pressure wound therapy (NPWT)
Trial: 30342697
Drug: Thrice weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrice weekly dressing changes with negative pressure wound therapy (NPWT)
Trial: 28007665
Drug: Daclizumab 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daclizumab 0.3 mg/kg
Trial: 28007665
Drug: Daclizumab 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daclizumab 1.2 mg/kg
Trial: 26139733
Drug: Propofol 1
RxNorm normalized name: propofol 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 1 mg/kg IV bolus followed by 0.5 mg/kg (Group P)
Trial: 26139733
Drug: Etomidate 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate 0.1 mg/kg followed by 0.05 mg/kg (Group E)
Trial: 15203886
Drug: Nicotinamide 50
RxNorm normalized name: Nicotinamide 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotinamide 50 mg/kg
Trial: 11466137
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of rt-PA
Trial: 9479357
Drug: TOR 60
RxNorm normalized name: ivacaftor 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TOR 60 mg daily
Trial: 9479357
Drug: TOR 240
RxNorm normalized name: intrinsic factor 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TOR 240 mg daily
Trial: 9479357
Drug: TAM 40
RxNorm normalized name: piracetam 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAM 40 mg daily
Trial: 7931484
Drug: VCR, AMD,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VCR, AMD, and radiation therapy
Trial: 7931484
Drug: VCR, AMD,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VCR, AMD, DOX, and radiation therapy
Trial: 2979259
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg cimetidine b.d. for up to 6 weeks
Trial: 29500310
Drug: Once-daily Norditropin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily Norditropin
Trial: 28211028
Drug: rhGH administration
RxNorm normalized name: rhGH
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhGH administration (0.029 mg kg-1 BW; 6 days/week for 3 weeks)
Trial: 9085026
Drug: 0.2% chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% chlorhexidine treatment
Trial: 9085026
Drug: Control (water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (water treatment)
Trial: 3996841
Drug: Cimetidine, two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine, two doses of 400 mg
Trial: 3996841
Drug: Cimetidine, four
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine, four doses of 400 mg
Trial: 3996841
Drug: Ranitidine, two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine, two doses of 150 mg
Trial: 3996841
Drug: Ranitidine, two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine, two doses of 300 mg
Trial: 30878897
Drug: Intravenous labetalol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous labetalol (20 mg initially, escalating doses up to 300 mg)
Trial: 30878897
Drug: Oral nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral nifedipine (10 mg initially, escalating doses up to 90 mg)
Trial: 24168291
Drug: 1-ml injection
RxNorm normalized name: ethyl chloride 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-ml injection of platelet-rich plasma (PRP)
Trial: 24168291
Drug: 1-ml injection
RxNorm normalized name: ethyl chloride 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-ml injection of platelet-poor plasma (PPP)
Trial: 20189753
Drug: IV paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV paracetamol 1 g every 6 hours and IV meperidine
Trial: 18050629
Drug: Medication group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication group (Brufen sustained-release capsules, 0.3 mg, b.i.d. for 3 days)
Trial: 15591725
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (AC) following the guidelines of the German Cancer Society (GCS)
Trial: 6171099
Drug: Intranasal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal administration of 5 mg polyguacyl
Trial: 6171099
Drug: Aerosol administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerosol administration of polyguacyl
Trial: 6171099
Drug: Intranasal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal administration of live influenza A (H1N1) vaccine
Trial: 23466353
Drug: 6% coriander
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6% coriander oil in unguentum leniens applied twice daily
Trial: 16584436
Drug: Aprotinin (AP)
RxNorm normalized name: Aprotinin
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aprotinin (AP) 280 mg followed by 70 mg per hour
Trial: 16584436
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (TA) 40 mg per kg followed by 40 mg per kg per hour
Trial: 53548
Drug: Prophylactic oral
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic oral metronidazole and kanamycin
Trial: 53548
Drug: Dietary and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary and mechanical preparation alone
Trial: 7386225
Drug: Ampicillin in
RxNorm normalized name: ampicillin Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin in a daily dose of 30 g for three days and 20 g for four days (excessive doses)
Trial: 7386225
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (moderate doses of ampicillin for one month)
Trial: 29617814
Drug: DPX-RSV(A) 10-μg
RxNorm normalized name: immunoglobulin G, human 10 % Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DPX-RSV(A) 10-μg
Trial: 29617814
Drug: DPX-RSV(A) 25-μg
RxNorm normalized name: tretinoin
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DPX-RSV(A) 25-μg
Trial: 23249758
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate 150 mg/day from day 3 to day 7 of the cycle (n=145)
Trial: 23249758
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of gonadotropins (GnRH agonist 0.1 mg and recombinant FSH 450 IU daily) (n=146)
Trial: 19169912
Drug: Triamcinolone cream
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone cream
Trial: 12139205
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg once daily (OD) alfuzosin
Trial: 12139205
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg three times daily (TID) alfuzosin
Trial: 7840365
Drug: Cognitive Behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavior Therapy
Trial: 1697914
Drug: YM617 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: YM617 0.4 mg
Trial: 1697914
Drug: YM617 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: YM617 0.2 mg
Trial: 1697914
Drug: YM617 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: YM617 0.1 mg
Trial: 17536871
Drug: Tobramycin (300mg/4mL)
RxNorm normalized name: Tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Tobramycin (300mg/4mL) administered twice daily via nebulizer for 4 weeks
Trial: 17536871
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered twice daily via nebulizer for 4 weeks
Trial: 14973517
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg/hydrochlorothiazide 12.5 mg (L/H)
Trial: 8273796
Drug: Intravenous metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous metronidazole (0.5g tid) and tobramycin (4 mg/kg tid)
Trial: 2596737
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of 1,500,000 IU streptokinase
Trial: 2596737
Drug: Routine anticoagulant
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine anticoagulant therapy (Control)
Trial: 1093634
Drug: 0.5 per
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 per cent. idoxuridine ointment (IDU)
Trial: 30852657
Drug: Vitamin D-fortified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D-fortified foods (yoghurt, cheese, eggs, crisp bread) providing 20 µg vitamin D3/day
Trial: 27773378
Drug: Checklist group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Checklist group (self-administered checklist and paper feedback)
Trial: 21066883
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group (manipulated acupuncture)
Trial: 16902063
Drug: High-fiber, low-fat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fiber, low-fat diet with daily aerobic exercise for 3 weeks
Trial: 6873549
Drug: 5-fluorouracil (5-FU)
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-fluorouracil (5-FU) at a single weekly dose of 15 mg/kg
Trial: 26297203
Drug: Levonorgestrel-releasing 52-mg
RxNorm normalized name: levonorgestrel
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Levonorgestrel-releasing 52-mg IUD (LNG-IUD)
Trial: 23972263
Drug: Octreotide-LAR (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide-LAR (20 mg intramuscular injections every 28 days for 3 years)
Trial: 23972263
Drug: Placebo (0.9%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0.9% sodium chloride solution every 28 days for 3 years)
Trial: 19233432
Drug: Naftopidil 50
RxNorm normalized name: Naftopidil
DrugBank: Naftopidil (DB12092)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Naftopidil 50 mg daily
Trial: 16945121
Drug: Tamsulosin 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.2 mg once daily
Trial: 20707784
Drug: Selegiline transdermal
RxNorm normalized name: Selegiline Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selegiline transdermal system (STS)
Trial: 10963930
Drug: Individually focused
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individually focused cognitive-behavioral treatment
Trial: 9011971
Drug: Buffer solution
RxNorm normalized name: Buffer Solution, pH 5.00, Reference Standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buffer solution
Trial: 8214269
Drug: 1% niclosamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% niclosamide lotion applied daily for five months
Trial: 8214269
Drug: Placebo lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo lotion applied daily for five months
Trial: 3323611
Drug: Higher BCKA
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher BCKA content supplement
Trial: 3323611
Drug: Lower BCKA
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower BCKA content supplement
Trial: 27930553
Drug: 0.9% sodium
RxNorm normalized name: LMD with 0.9% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% sodium chloride injection
Trial: 20041430
Drug: Ginkgo fresh
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo fresh plant extract tablets
Trial: 20041430
Drug: EGb 761
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGb 761 tablets
Trial: 11873071
Drug: Subcutaneous recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous recombinant interleukin-2 (rIL-2) 4.5 MIU
Trial: 11873071
Drug: Subcutaneous recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous recombinant interleukin-2 (rIL-2) 7.5 MIU
Trial: 11873071
Drug: Subcutaneous recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous recombinant interleukin-2 (rIL-2)
Trial: 8871752
Drug: Weekly Epoetin
RxNorm normalized name: Epoetin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly Epoetin alfa regimen (600 IU/kg)
Trial: 8871752
Drug: Daily Epoetin
RxNorm normalized name: Epoetin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily Epoetin alfa regimen (300 IU/kg)
Trial: 23152839
Drug: Mipomersen 200
RxNorm normalized name: mipomersen 200 mg/mL subcutaneous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mipomersen 200 mg weekly subcutaneous injections (n = 39)
Trial: 20212297
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for chronic diseases
Trial: 17352962
Drug: Watermelon juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Watermelon juice (780 g/day)
Trial: 17352962
Drug: Watermelon juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Watermelon juice (1560 g/day)
Trial: 17352962
Drug: Control (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (0 g watermelon juice)
Trial: 11934658
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg estradiol and 1 mg norethisterone acetate
Trial: 15730171
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg estradiol and 5 mg norethindrone
Trial: 9539585
Drug: Univent tube
RxNorm normalized name: Sus scrofa fallopian tube preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Univent tube with bronchial blocker (R-UBB)
Trial: 22015616
Drug: Intracoronary bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary bolus administration of abciximab
Trial: 22015616
Drug: Intravenous bolus
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bolus administration of abciximab
Trial: 16360543
Drug: Gemcitabine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine (1000 mg/m2, days 1, 8) plus Docetaxel (75 mg/m2, day 1)
Trial: 16360543
Drug: Capecitabine (1250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capecitabine (1250 mg/m2, bid days 1-14) plus Docetaxel
Trial: 12037739
Drug: Modified intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified intravenous glucose tolerance test (IVGTT)
Trial: 12037739
Drug: Insulin sensitivity
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin sensitivity index (SI)
Trial: 12037739
Drug: Insulin secretion
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin secretion (AIR(Glucose))
Trial: 1616162
Drug: Atropine (0.02
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine (0.02 mg/kg)
Trial: 20517827
Drug: Placebo (isotonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (isotonic saline solution)
Trial: 8539548
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (IVIG) 1 g/kg body weight per day over 2 consecutive days
Trial: 8539548
Drug: Observation (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Observation (no specific therapy)
Trial: 338254
Drug: 3 x
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 x 20 mg piribedil tablets
Trial: 338254
Drug: 1 x
RxNorm normalized name: Black Cohosh 1 X Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 x 50 mg piribedil in a sustained-release tablet formulation
Trial: 31511330
Drug: Fingolimod 0.5
RxNorm normalized name: fingolimod 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fingolimod 0.5 mg/d
Trial: 25419615
Drug: Fingolimod 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fingolimod 1.25 mg/d
Trial: 25419615
Drug: Other disease-modifying
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other disease-modifying treatments
Trial: 25419615
Drug: Corticosteroid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid treatment for relapses
Trial: 25419615
Drug: Postmarketing setting
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postmarketing setting (Fingolimod 0.5 mg/d)
Trial: 19699855
Drug: Nurse-administered disease-management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-administered disease-management intervention combining patient self-management support and provider medication management
Trial: 19699855
Drug: Nurse-administered disease-management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-administered disease-management intervention
Trial: 31932458
Drug: Sulfonylurea treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfonylurea treatment
Trial: 3553493
Drug: Hydrochlorothiazide (added
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (added to treatment)
Trial: 27869225
Drug: Noisy galvanic
RxNorm normalized name: OCTINOXATE 0.068 g in 1 g TOPICAL LIPSTICK [ESIKA PRO HD COLOR HIGH DEFINITION COLOR SPF 20 (HD BERRY BALCANIC) - RED]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noisy galvanic vestibular stimulation (nGVS) for 30 minutes twice with a 4-hour interval
Trial: 19439364
Drug: Modafinil (200-300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil (200-300 mg/day depending on weight)
Trial: 20860068
Drug: Methylphenidate (20-30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (20-30 mg/day depending on weight)
Trial: 15754390
Drug: Corticosteroids at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids at 60 mg or more daily with or without anti-viral drugs within 10 days after diagnosis (early high-dose group)
Trial: 15754390
Drug: Non-early high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-early high-dose group (treated more than 10 days or untreated with corticosteroids)
Trial: 6192894
Drug: BCVP (maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCVP (maintenance therapy for responders)
Trial: 6192894
Drug: COPA (maintenance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COPA (maintenance therapy for responders)
Trial: 28478716
Drug: Valerian (530
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valerian (530 mg) nightly 1 hour before sleep for 4 weeks
Trial: 24722261
Drug: MDCO-2010 (highest
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDCO-2010 (highest dosage groups)
Trial: 16965431
Drug: Calcipotriol ointment
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol ointment twice daily
Trial: 16965431
Drug: Dithranol cream
RxNorm normalized name: Zithranol
DrugBank: Anthralin (DB11157)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dithranol cream once daily
Trial: 15788020
Drug: Protein-rich liquid
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein-rich liquid supplement (PR; 200 kcal and 20 g protein day(-1))
Trial: 15788020
Drug: Protein-rich liquid
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein-rich liquid supplement (PR; 200 kcal and 20 g protein day(-1)) + nandrolone decanoate injections (PR/N) 25 mg i.m. every third week
Trial: 11849631
Drug: Ortho Evra/Evra
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ortho Evra/Evra transdermal patch (3 consecutive 7-day patches for 21 days with 1 patch-free week)
Trial: 11849631
Drug: Ortho Evra/Evra
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ortho Evra/Evra transdermal patch
Trial: 10450383
Drug: 0.5 ml
RxNorm normalized name: ethanol 0.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 ml carbachol intracamerally (carbachol group)